Top Clinical Trials companies in Australia by Dividend Per Share

This ranking features the top 15 Clinical Trials companies in Australia ranked by Dividend Per Share, averaging a Dividend Per Share of USD 0.01, for February 06, 2025.
#
Name
Dividend Per Share
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 2.62
June 30, 2024 USD 169.95 -0.56%

Australia

2
USD 0.07
June 30, 2024 USD 2.33 0.08%

Australia

3
USD 0.03
June 30, 2024 USD 7.27 0.71%

Australia

4
USD 0.03
June 30, 2024 USD 0.74 0.62%

Australia

5
USD -0.00
June 30, 2024 USD 2.46 10.79%

Australia

6
USD -0.00
June 30, 2024 USD 2.09 0.97%

Australia

7
USD -0.00
June 30, 2024 USD 2.04 -5.56%

Australia

8
USD -0.00
June 30, 2024 USD 1.67 2.45%

Australia

9
USD -0.00
June 30, 2024 USD 1.90 -4.74%

Australia

10
USD -0.00
June 30, 2024 USD 1.23 -0.40%

Australia

11
USD -0.00
Dec. 31, 2023 USD 18.33 -0.84%

Australia

12
USD -0.00
June 30, 2024 NA

Australia

13
USD -0.00
June 30, 2024 USD 4.80 5.03%

Australia

14
USD -0.00
Dec. 31, 2023 USD 6.16 2.82%

Australia

15
USD -0.00
June 30, 2024 USD 0.74 1.48%

Australia

Frequently Asked Questions
  • Which Clinical Trials company in Australia has the highest Dividend Per Share ?

    The Clinical Trials company in Australia with the highest Dividend Per Share is CSL Limited (ASX: CSL.AX) at USD 2.62.

  • Which Clinical Trials company in Australia has the lowest Dividend Per Share ?

    The Clinical Trials company in Australia with the lowest Dividend Per Share is Cogstate Limited (ASX: CGS.AX) at USD -0.00.

SV Wall Street